In one paragraphArticle in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Rita MastrogiacomoDepartment of Chemistry, University of Bari Aldo Moro, Via E. Orabona 4, Bari 70126, Italy.ORCID 0009-0007-2184-9205 Daniela Valeria MinieroDepartment Medicine and Surgery, LUM University Giuseppe Degennaro, Casamassima 70010, Italy.
Mariagrazia RulloDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari 70125, Italy.ORCID 0000-0001-5304-6764 Federica RizziInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.ORCID 0000-0001-8891-4218 Gianluca MinerviniInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.
Annamaria PannielloInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.
Marinella StriccoliInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.ORCID 0000-0002-5366-691X Elisabetta FanizzaDepartment of Chemistry, University of Bari Aldo Moro, Via E. Orabona 4, Bari 70126, Italy.ORCID 0000-0001-6293-9388 Roberto ComparelliInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.
Maria Lucia CurriDepartment of Chemistry, University of Bari Aldo Moro, Via E. Orabona 4, Bari 70126, Italy.ORCID 0000-0002-0261-8379 Marco CattoDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari 70125, Italy.ORCID 0000-0002-8411-304X Grazia Maria LiuzziDepartment of Biosciences, Biotechnologies and Environment, University of Bari "Aldo Moro", Bari 70126, Italy.
Leonardo PisaniDepartment of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, Bari 70125, Italy.ORCID 0000-0002-4198-3897 Tiziana LatronicoDepartment of Biosciences, Biotechnologies and Environment, University of Bari "Aldo Moro", Bari 70126, Italy.ORCID 0000-0001-6971-5416 Nicoletta DepaloInstitute for Chemical and Physical Processes (IPCF)-CNR SS Bari, Via Orabona 4, Bari 70126, Italy.ORCID 0000-0002-2107-2762 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Neurodegenerative disorders, including Alzheimer's and Parkinson's diseases, urgently require new therapeutic strategies. Monoamine oxidase B (MAO B), a mitochondrial enzyme involved in oxidative stress and neurotransmitter metabolism, has emerged as a promising target for neuroprotection. A 5-substituted-1
Indexed as
AntioxidantsBrainDrug CarriersLipidsMonoamine Oxidase InhibitorsNanostructuresNeurodegenerative DiseasesAnimalsBlood-Brain BarrierCarbon Quantum DotsCell Line, TumorDrug Delivery SystemsHumansMonoamine OxidaseNeuroprotective AgentsAntioxidantsDrug CarriersLipidsMonoamine OxidaseMonoamine Oxidase InhibitorsNeuroprotective Agentsantioxidant activityblood–brain barrierMAO B inhibitornanostructured lipid carriersneurodegenerative diseases
Identifiers
PMID41962139
PMCPMC13147330
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390